Alston & Bird is noted for representing Fortress Biotech, Inc., and Caelum Biosciences Inc. in a deal with Alexion Pharmaceuticals Inc. to develop a treatment for a rare systemic disorder.
In the News
January 31, 2019
The Deal | Alexion, Caelum Collaborate
Media Contact